Fenbufen

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C16H14O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9815R1WR9B, chemically known as propionic acid, 3-(4-biphenylylcarbonyl)- but generally known as fenbufen, which bears US NIH Compound Identifier 3335. European Medicines Agency schedules Fenbufen in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07543MIG. The term FENBUFEN is an International Non-Proprietary Name. World Health Organization schedules fenbufen in its Anatomical Therapeutic Chemical (ATC) Classification. FENBUFEN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule fenbufen under HS 29183000 and SITC 51395. As of Q4 2014, FENBUFEN remains the US FDA Preferred Term for this commodity. Fenbufen bears US NLM identifiers UMLS ID C0060156 and NCI Concept Code C80548. SMILES: O=C(C1CCC(C2CCCCC2)CC1)CCC(=O)O.